Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Dr Mayfong Mayxay

Dr Mayfong Mayxay

Contact information


mayfong@tropmedres.ac

Podcast interview

Mayfong Mayxay tells us about the importance of conducting field research in Laos, to better inform national treatment guidelines.

Mayfong Mayxay

Vice-President of the Lao University of Health Sciences, Ministry of Health

  • Associate Professor, Lao University of Health Sciences

Field Research

Mayfong Mayxay has been working for LOMWRU since the establishment of the Unit in 2000. He has led clinical trials of antimalarials and other field clinical research in Laos since 2000 and between 2002 and 2006, under the supervision of Prof. Nick White and Prof. Paul Newton, he carried out his Wellcome fellowship training in clinical tropical medicine with the research entitled “Clinical and laboratory studies to guide Lao national antimalarial drug policy” which was associated with Mahidol and Oxford Universities. The results from his research had led to the change of the Lao national policy for uncomplicated falciparum malaria treatment from chloroquine and sulphadoxine-pyrimethamine to ACTs (artemether-lumefantrine) in 2005. 

Mayfong is the Head of the Field Research of LOMWRU, Associate Professor, and Vice-President of the Lao University of Health Sciences, Ministry of Health. He has also been an Honorary Visiting Research Fellow in Tropical Medicine at Oxford since 2009. His particular research interests include antimalarial drug resistance, causes of fever, dengue, rickettsial infections, Japanese encephalitis virus infection, and infantile beriberi

Key publications

Recent publications

More publications